These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 16055015)
1. Resisting resistance. Ewan S Drug Discov Today; 2005 Aug; 10(15):1015. PubMed ID: 16055015 [No Abstract] [Full Text] [Related]
2. Clinical relevance of P-glycoprotein with respect to the application of resistance modifiers. Scheulen ME Int J Clin Pharmacol Ther; 1998 Jan; 36(1):41-5. PubMed ID: 9476147 [No Abstract] [Full Text] [Related]
3. Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer. Wang SJ; Bourguignon LY Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):19-24. PubMed ID: 16415424 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Wang SJ; Bourguignon LY Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188 [TBL] [Abstract][Full Text] [Related]
5. Clinical cancer research 2001: new agents and therapies. Verweij J; de Vries EG Drug Resist Updat; 2001 Aug; 4(4):217-23. PubMed ID: 11991676 [No Abstract] [Full Text] [Related]
13. Novel types of carborane-carrier hyaluronan derivatives via "click chemistry". Di Meo C; Panza L; Campo F; Capitani D; Mannina L; Banzato A; Rondina M; Rosato A; Crescenzi V Macromol Biosci; 2008 Jul; 8(7):670-81. PubMed ID: 18412288 [TBL] [Abstract][Full Text] [Related]
14. [Evolution of chemotherapy of cancer. Conceptuals models]. Lopez M Clin Ter; 2000; 151(1):49-55. PubMed ID: 10822882 [No Abstract] [Full Text] [Related]
15. Progressive thoughts about progressive disease. Shah NP Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5229-31. PubMed ID: 17875748 [No Abstract] [Full Text] [Related]
16. An insight on hyaluronic acid in drug targeting and drug delivery. Yadav AK; Mishra P; Agrawal GP J Drug Target; 2008 Feb; 16(2):91-107. PubMed ID: 18274931 [TBL] [Abstract][Full Text] [Related]
17. Current clinical and research approaches to optimizing regional chemotherapy: novel strategies generated through a better understanding of drug pharmacokinetics, drug resistance, and the development of clinically relevant animal models. Beasley GM; Kahn L; Tyler DS Surg Oncol Clin N Am; 2008 Oct; 17(4):731-58, vii-viii. PubMed ID: 18722915 [TBL] [Abstract][Full Text] [Related]
18. Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents. O'Connor R; Clynes M; Dowling P; O'Donovan N; O'Driscoll L Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):805-17. PubMed ID: 18028026 [TBL] [Abstract][Full Text] [Related]
19. Targeted therapies: the answer to individualized treatment? Hutchinson L Nat Clin Pract Oncol; 2007 Jun; 4(6):323. PubMed ID: 17534387 [No Abstract] [Full Text] [Related]
20. Hyaluronan substratum induces multidrug resistance in human mesenchymal stem cells via CD44 signaling. Liu CM; Chang CH; Yu CH; Hsu CC; Huang LL Cell Tissue Res; 2009 Jun; 336(3):465-75. PubMed ID: 19350274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]